Jana Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-12,000
Closed -$2.02M 65
2018
Q1
$2.02M Buy
+12,000
New +$2.01M 0.06% 42
2016
Q2
Sell
-446,893
Closed -$120M 51
2016
Q1
$120M Sell
446,893
-717,770
-62% -$205M 2.27% 12
2015
Q4
$364M Sell
1,164,663
-722,268
-38% -$215M 5.13% 7
2015
Q3
$513M Buy
1,886,931
+268,546
+17% +$82.5M 5.78% 5
2015
Q2
$491M Sell
1,618,385
-3,467
-0.2% -$1.03M 2.92% 12
2015
Q1
$483M Buy
+1,621,852
New +$462M 2.8% 11
2014
Q4
Sell
-2,514,701
Closed -$607M 56
2014
Q3
$607M Sell
2,514,701
-139,627
-5% -$31.2M 3.14% 9
2014
Q2
$592M Buy
2,654,328
+1,752,440
+194% +$363M 3.66% 7
2014
Q1
$186M Buy
901,888
+404,990
+82% +$80.2M 2.18% 18
2013
Q4
$83.5M Buy
+496,898
New +$77.7M 1.06% 28

Other funds holding AGN

Jana Partners's AGN Position: Q2 2018 in Review

Jana Partners sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 12,000 shares — an estimated $2.02M sold.

Jana Partners first reported a position in AGN in Q4 2013 and held it in 10 quarters. The position peaked at $607M in Q3 2014. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

  • Jana Partners reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
  • Jana Partners sold 12,000 Allergan plc shares in Q2 2018, an estimated $2.02M.
  • Jana Partners first reported a position in Allergan plc in Q4 2013 and held it in 10 quarters.
  • Jana Partners's Allergan plc position peaked at $607M in Q3 2014.
  • 1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on Jana Partners's 13F filing for Q2 2018, filed 14 Aug 2018.